Align Technology (NASDAQ:ALGN) Posts Quarterly Earnings Results, Beats Expectations By $0.02 EPS

Align Technology (NASDAQ:ALGN) posted its quarterly earnings data on Wednesday. The medical equipment provider reported $2.64 EPS for the quarter, beating the consensus estimate of $2.62 by $0.02, FiscalAI reports. Align Technology had a return on equity of 15.82% and a net margin of 10.50%.The firm had revenue of $1.06 billion during the quarter, compared to the consensus estimate of $1.05 billion. During the same period in the prior year, the company earned $2.49 EPS. The firm’s revenue was up 4.3% compared to the same quarter last year.

Here are the key takeaways from Align Technology’s conference call:

• Record Q2 revenue of $1.06 billion rose 4.3% year over year, while clear aligner shipments reached a record 692,000 cases, up 7.4%, led by double-digit growth in APAC, EMEA, and Latin America.
• Clear aligner performance and operational efficiencies lifted non-GAAP operating margin to 22.9%, up 1.6 percentage points year over year, exceeding expectations; full-year non-GAAP operating margin guidance remains approximately 23%.
• Systems and services revenue fell 10.8% to $185.3 million as capital-equipment demand remained soft and customers shifted toward lower-priced scanners, rentals, and leases. Align now expects full-year systems and services revenue to decline 6%–8%.
• Align expects Q3 revenue of $1.00 billion–$1.02 billion, with clear aligner volume growth in the mid-single digits but lower sequential ASPs; Q3 GAAP results will also include approximately $35 million–$50 million of restructuring and accelerated-depreciation charges.
• Following discussions with Elliott Management, Align plans to add three independent directors, conduct a strategic and operating-model review, and increase 2026 share repurchases to approximately $400 million–$500 million, while targeting at least 100 basis points of operating-margin improvement in 2027.

Align Technology Trading Down 2.9%

Align Technology stock traded down $5.24 during mid-day trading on Thursday, hitting $174.84. The company’s stock had a trading volume of 459,506 shares, compared to its average volume of 1,114,430. The firm has a market capitalization of $12.52 billion, a PE ratio of 29.20, a price-to-earnings-growth ratio of 1.80 and a beta of 1.67. Align Technology has a 1 year low of $122.00 and a 1 year high of $200.43. The stock’s fifty day moving average is $174.24 and its two-hundred day moving average is $175.25.

Align Technology News Summary

Here are the key news stories impacting Align Technology this week:

• Positive Sentiment: Q2 results exceeded expectations. Align reported adjusted earnings of $2.64 per share, ahead of analyst estimates of approximately $2.56-$2.62, while revenue reached $1.056 billion versus expectations near $1.05 billion. Revenue increased 4.3% year over year, and earnings rose from $2.49 per share in the prior-year quarter. Align Technology Announces Second Quarter 2026 Financial Results
• Positive Sentiment: Activist-driven changes could improve shareholder value. Align will add three independent directors and conduct an operational review following discussions with Elliott. Management said the initiatives are intended to strengthen governance, improve execution and support long-term growth, potentially creating a catalyst for the stock. Align Technology to overhaul board following engagement with Elliott
• Neutral Sentiment: Management reaffirmed its 2026 outlook. The company’s broader growth expectations remain intact, while its Invisalign business was described as solid. Align also highlighted its Invisalign Ortho Summit and plans for connected digital orthodontics, supporting its longer-term technology strategy. Align Technology Hosts 2026 Invisalign Ortho Summit
• Negative Sentiment: Near-term growth and guidance remain concerns. Third-quarter revenue guidance of roughly $1.0 billion was slightly below consensus, and analysts cited weakness in Align’s systems business as limiting upside. Needham maintained a Hold rating, indicating that the earnings beat and clear-aligner performance may not be enough to offset softer systems trends and execution risks. Align Technology Hold Rating Maintained

Align Technology declared that its board has approved a share repurchase plan on Wednesday, April 29th that allows the company to repurchase $200.00 million in outstanding shares. This repurchase authorization allows the medical equipment provider to repurchase up to 1.6% of its stock through open market purchases. Stock repurchase plans are usually a sign that the company’s board believes its stock is undervalued.

Wall Street Analyst Weigh In

Several equities analysts have recently weighed in on the stock. BMO Capital Markets began coverage on shares of Align Technology in a research note on Wednesday, July 8th. They issued an “outperform” rating and a $209.00 price target on the stock. UBS Group restated a “neutral” rating and set a $189.00 target price on shares of Align Technology in a report on Thursday, July 23rd. Weiss Ratings upgraded Align Technology from a “hold (c-)” rating to a “hold (c)” rating in a research report on Friday, July 17th. Citigroup started coverage on Align Technology in a research report on Wednesday, April 15th. They set a “buy” rating and a $240.00 price objective on the stock. Finally, Evercore upped their target price on Align Technology from $200.00 to $220.00 in a report on Thursday, April 30th. One research analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating and six have given a Hold rating to the stock. According to data from MarketBeat, Align Technology presently has a consensus rating of “Moderate Buy” and a consensus target price of $206.36.

Hedge Funds Weigh In On Align Technology

Several large investors have recently modified their holdings of ALGN. Sunbelt Securities Inc. increased its position in shares of Align Technology by 222.4% during the 4th quarter. Sunbelt Securities Inc. now owns 158 shares of the medical equipment provider’s stock worth $25,000 after purchasing an additional 109 shares during the last quarter. Caitong International Asset Management Co. Ltd lifted its position in Align Technology by 1,773.3% in the third quarter. Caitong International Asset Management Co. Ltd now owns 281 shares of the medical equipment provider’s stock valued at $35,000 after buying an additional 266 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in Align Technology in the second quarter valued at about $36,000. Global Retirement Partners LLC boosted its stake in Align Technology by 101.8% during the fourth quarter. Global Retirement Partners LLC now owns 230 shares of the medical equipment provider’s stock worth $36,000 after buying an additional 116 shares during the period. Finally, MUFG Securities EMEA plc purchased a new position in Align Technology during the second quarter worth about $38,000. Institutional investors and hedge funds own 88.43% of the company’s stock.

About Align Technology

Align Technology, Inc (NASDAQ: ALGN) pioneered the use of digital technology in orthodontics through the development of the Invisalign system, a series of clear, removable aligners that provide an alternative to traditional metal braces. Since its founding in 1997 by Zia Chishti and Kelsey Wirth, the Tempe, Arizona–based company has expanded its focus to include intraoral scanners, CAD/CAM software for dental laboratories and comprehensive digital dentistry solutions.

The company’s signature Invisalign system leverages 3D imaging and computer-aided design (CAD) to create customized aligners that gradually reposition teeth, improving patient comfort and treatment predictability.